Deel's Alex Bouaziz and Clarity's Michael Matias explain why a one-off identity check at hiring no longer holds as deepfake candidates reach real interviews.
Deel, the global people platform, has acquired Clarity, an AI cybersecurity company that specialises in identity verification, deepfake detection and fraud prevention.
Build an investment platform around investor trust and clear business goals—not appearances. Prioritize investor conversations, practical systems, and an aligned team.
If you’re thinking about launching an institutional investment platform, the legal side is only part of the story.
Investopia signs MoU with SIEF to enhance UAE-China economic relations, promoting investment and entrepreneurship across sectors like SMEs and the new economy.
Avaloq expands into Dubai’s DIFC to support digital transformation in the GCC’s wealth management sector, helping financial institutions enhance operations, build client trust, and stay a
Polling failures highlight the challenge of using data effectively. In a world overloaded with information, great storytelling requires balancing facts with engagement.
Oracle plans a $5 billion investment in the UK over five years to expand its cloud infrastructure, supporting AI innovation and multicloud capabilities, helping businesses and the public
GLEIF and Open Ownership introduce GODIN to promote open data practices, enhance global interoperability, and connect organizations through the LEI system, driving transparency and access
The 2 August milestone has passed. TTEC Digital's Amanda Panks on what has actually changed for banks, where the gaps are, and why the next test is the AI customers never
NetApp and Oracle have announced a fully managed, OCI-native storage service based on ONTAP, targeting AI and regulated enterprise workloads, due within 12 months.
intelliflo has bought Mabel Insights, folding its whole-of-market portfolio research tools into intelliflo office while keeping them free for advisers.
ANB033 significantly reduced intestinal damage and symptoms versus placebo in a Phase 1b gluten-challenge study, with a late-stage trial planned for 2027.
An independent Italian study found MicroPulse transscleral laser therapy reduced intraocular pressure by 37% over 24 months across early to advanced glaucoma.